Aberrant blood-brain barrier dynamics in cerebral small vessel disease - a review of associations, pathomechanisms and therapeutic potentials

Abstract

This review explores the pivotal role of the blood-brain barrier (BBB) in maintaining central nervous system (CNS) homeostasis and its dynamic involvement in the pathogenesis of cerebral small vessel disease (CSVD), i.e., the major precursor of age-related neurodegenerative diseases such as vascular dementia and Alzheimer’s disease. It underscores the BBB as a critical physiological boundary that regulates the exchange between the bloodstream and the cerebral milieu through a complex and dynamic interface composed of endothelial cells, astrocyte endfeet, and pericytes. The integrity of this barrier is paramount for neural function, shielding the brain from toxicants and pathogens while facilitating the transport of essential nutrients. Nevertheless, BBB dysfunction is recognized as a lead in the pathogenesis of neurodegeneration including CSVD, emphasizing the need for focused research on maintaining or restoring BBB function. This review highlights recent advancements in our understanding of BBB dynamics in both health and disease states, its involvement in CSVD pathomechanisms, and the challenges and future directions of translational research and emerging technologies. The review advocates for a multidisciplinary approach to uncover the complexity of BBB dysfunction in CSVD, as well as insights into potential therapeutic targets aimed at preserving BBB integrity, thereby minimizing its impact given the notable world’s aging demographics.

Keywords

Blood-brain barrier / cerebral small vessel disease / BBB dysfunction / translational research

References

[1] Montagne A,Sagare AP.APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.Nature2020;581:71-6

[2] Sweeney MD,Sagare AP.Vascular dysfunction-the disregarded partner of Alzheimer's disease.Alzheimers Dement2019;15:158-67

[3] Wevers NR.Microfluidic models of the neurovascular unit: a translational view.Fluids Barriers CNS2023;20:86 PMCID:PMC10680291

[4] Zhao Z,Betsholtz C.Establishment and dysfunction of the blood-brain barrier.Cell2015;163:1064-78 PMCID:PMC4655822

[5] Iliff JJ,Liao Y.A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.Sci Transl Med2012;4:147ra111 PMCID:PMC3551275

[6] Nedergaard M.Glymphatic failure as a final common pathway to dementia.Science2020;370:50-6 PMCID:PMC8186542

[7] Jessen NA,Lundgaard I.The glymphatic system: a beginner’s guide.Neurochem Res2015;40:2583-99 PMCID:PMC4636982

[8] Backhouse EV,Wardlaw JM.Cerebral small vessel disease: early-life antecedents and long-term implications for the brain, aging, stroke, and dementia.Hypertension2024;81:54-74 PMCID:PMC10734792

[9] Wardlaw JM,Dichgans M.Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.Lancet Neurol2013;12:483-97 PMCID:PMC3836247

[10] Abdul Hamid H,Okon U.Is cerebral small vessel disease a central nervous system interstitial fluidopathy?.IBRO Neurosci Rep2024;16:98-105 PMCID:PMC11240297

[11] Duering M,Brodtmann A.Neuroimaging standards for research into small vessel disease-advances since 2013.Lancet Neurol2023;22:602-18

[12] Frisoni GB.STRIVEing to describe small vessel disease.Lancet Neurol2023;22:548-9

[13] Wardlaw JM,Dichgans M.Small vessel disease: mechanisms and clinical implications.Lancet Neurol2019;18:684-96

[14] Osmaniye D,Sağlık BN.Design, synthesis and molecular docking and ADME studies of novel hydrazone derivatives for AChE inhibitory, BBB permeability and antioxidant effects.J Biomol Struct Dyn2023;41:9022-38

[15] Lee MJ,Han J.Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration.J Cereb Blood Flow Metab2020;40:1546-61 PMCID:PMC7308523

[16] Zhang R,Wang S.Decreased cerebral blood flow and delayed arterial transit are independently associated with white matter hyperintensity.Front Aging Neurosci2022;14:762745 PMCID:PMC9197206

[17] Chen J,Yang LX.MYPT1(SMKO) mice function as a novel spontaneous age- and hypertension-dependent animal model of CSVD.Transl Stroke Res2024;15:606-19

[18] Dingezweni S.The blood-brain barrier.South Afr J Anaesth Analg2020;26:S32-4

[19] Taoka T.Imaging for central nervous system (CNS) interstitial fluidopathy: disorders with impaired interstitial fluid dynamics.Jpn J Radiol2021;39:1-14 PMCID:PMC7813706

[20] Menaceur C,Fenart L.The blood-brain barrier, an evolving concept based on technological advances and cell-cell communications.Cells2021;11:133 PMCID:PMC8750298

[21] Abbott NJ,Dolman DE,Begley DJ.Structure and function of the blood-brain barrier.Neurobiol Dis2010;37:13-25

[22] Badaut J,Thorne RG.Blood-brain borders: a proposal to address limitations of historical blood-brain barrier terminology.Fluids Barriers CNS2024;21:3 PMCID:PMC10770911

[23] Iadecola C.The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease.Neuron2017;96:17-42 PMCID:PMC5657612

[24] Wolburg H.Tight junctions of the blood-brain barrier: development, composition and regulation.Vascul Pharmacol2002;38:323-37

[25] Takata F,Matsumoto J.Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction.Front Cell Neurosci2021;15:661838 PMCID:PMC8475767

[26] Alvarez JI,Prat A.Glial influence on the blood brain barrier.Glia2013;61:1939-58 PMCID:PMC4068281

[27] Sofroniew MV.Astrocytes: biology and pathology.Acta Neuropathol2010;119:7-35 PMCID:PMC2799634

[28] Filosa JA.Astrocyte regulation of cerebral vascular tone.Am J Physiol Heart Circ Physiol2013;305:H609-19 PMCID:PMC3761330

[29] Iadecola C.Glial regulation of the cerebral microvasculature.Nat Neurosci2007;10:1369-76

[30] Sofroniew MV.Molecular dissection of reactive astrogliosis and glial scar formation.Trends Neurosci2009;32:638-47 PMCID:PMC2787735

[31] Winkler EA,Zlokovic BV.Central nervous system pericytes in health and disease.Nat Neurosci2011;14:1398-405

[32] Armulik A,Betsholtz C.Pericytes: developmental, physiological, and pathological perspectives, problems, and promises.Dev Cell2011;21:193-215

[33] Dalkara T,Yemisci M.Brain microvascular pericytes in health and disease.Acta Neuropathol2011;122:1-9

[34] Proebstl D,Woodfin A.Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo.J Exp Med2012;209:1219-34 PMCID:PMC3371725

[35] Sagare AP,Zlokovic BV.Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.Cold Spring Harb Perspect Med2012;2:a011452 PMCID:PMC3475405

[36] del Río-Hortega Bereciartu J. Pío del Río-Hortega: the revolution of glia.Anat Rec2020;303:1232-41

[37] Brown LS,Courtney JM,Howells DW.Pericytes and neurovascular function in the healthy and diseased brain.Front Cell Neurosci2019;13:282 PMCID:PMC6611154

[38] Rey JA,Najjoum CM.Perivascular network segmentations derived from high-field MRI and their implications for perivascular and parenchymal mass transport in the rat brain.Sci Rep2023;13:9205 PMCID:PMC10244386

[39] Tremblay MÈ,Samson L,Sierra A.From the Cajal alumni Achúcarro and Río-Hortega to the rediscovery of never-resting microglia.Front Neuroanat2015;9:45 PMCID:PMC4396411

[40] Sierra A,Del Río-Hortega J,Garrosa M.The “Big-Bang” for modern glial biology: translation and comments on Pío del Río-Hortega 1919 series of papers on microglia.Glia2016;64:1801-40

[41] Dudiki T,Mahajan G.Microglia control vascular architecture via a TGFβ1 dependent paracrine mechanism linked to tissue mechanics.Nat Commun2020;11:986 PMCID:PMC7033106

[42] Haruwaka K,Tachibana Y.Dual microglia effects on blood brain barrier permeability induced by systemic inflammation.Nat Commun2019;10:5816 PMCID:PMC6925219

[43] Lehmann ML,Cooper HA,Kigar SL.Decoding microglia responses to psychosocial stress reveals blood-brain barrier breakdown that may drive stress susceptibility.Sci Rep2018;8:11240 PMCID:PMC6062609

[44] Pinosanu LR,Glavan D.Neuroglia cells transcriptomic in brain development, aging and neurodegenerative diseases.Aging Dis2023;14:63-83 PMCID:PMC9937697

[45] Domogatskaya A,Tryggvason K.Functional diversity of laminins.Annu Rev Cell Dev Biol2012;28:523-53

[46] Marchetti L.Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation.Vasc Biol2020;2:H1-18 PMCID:PMC7439848

[47] Daneman R,Kebede AA.Pericytes are required for blood-brain barrier integrity during embryogenesis.Nature2010;468:562-6 PMCID:PMC3241506

[48] Yamazaki Y.Blood-brain barrier dysfunction and the pathogenesis of Alzheimer's disease.Int J Mol Sci2017;18:1965 PMCID:PMC5618614

[49] Menon DK,Wright DW.The Demographics and Clinical Assessment Working Group of the International and Interagency Initiative toward Common Data Elements for Research on Traumatic Brain Injury and Psychological HealthPosition statement: definition of traumatic brain injury.Arch Phys Med Rehabil2010;91:1637-40

[50] Li Y,Zhang X.Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden.J Neurol2017;264:1474-81

[51] Iadecola C.The pathobiology of vascular dementia.Neuron2013;80:844-66 PMCID:PMC3842016

[52] Tabdili Y,Brathaban N.Blood-brain barrier dysfunction is associated with A/T/N biomarkers and cognition in the aging brain.Alzheimer's Dementia2022;18:e066675

[53] Sweeney MD,Montagne A,Zlokovic BV.Blood-brain barrier: from physiology to disease and back.Physiol Rev2019;99:21-78 PMCID:PMC6335099

[54] Custodia A,Rodríguez-Arrizabalaga M.Biomarkers assessing endothelial dysfunction in Alzheimer's disease.Cells2023;12:962 PMCID:PMC10047803

[55] Joo J,Park HJ.Blood biomarkers in patients with parkinson’s disease: a review in context of anesthetic care.Diagnostics2023;13:693 PMCID:PMC9955162

[56] de Rus Jacquet A,Denis HL.The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson's disease.Nat Commun2023;14:3651 PMCID:PMC10282096

[57] Cash A.Mechanisms of blood-brain barrier dysfunction in traumatic brain injury.Int J Mol Sci2020;21:3344 PMCID:PMC7246537

[58] Huang J,Xie C.Pramipexole protects against traumatic brain injury-induced blood-brain barrier (BBB) dysfunction.Neurotox Res2022;40:1020-8

[59] Zimmermann J,Krauthausen M.IL-17A facilitates entry of autoreactive T-cells and granulocytes into the CNS during EAE.Neuromol Med2023;25:350-9 PMCID:PMC10514131

[60] Kamimura D.Neural stimulations regulate the infiltration of immune cells into the CNS.J Intern Med2019;286:259-67

[61] Vezzani A.Brain autonomous mechanisms of seizure-induced BBB dysfunction: brain pathways to vessels dysfunction.Epilepsy Curr2012;12:69-71 PMCID:PMC3316359

[62] Mohi-Ud-Din R,Mir PA.Dysfunction of ABC transporters at the surface of BBB: potential implications in intractable epilepsy and applications of nanotechnology enabled drug delivery.Curr Drug Metab2022;23:735-56

[63] Manukjan N,Fulton D,Foulquier S.A systematic review of WNT signaling in endothelial cell oligodendrocyte interactions: potential relevance to cerebral small vessel disease.Cells2020;9:1545 PMCID:PMC7349551

[64] Walsh J,Sari H.Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.Brain2021;144:1361-71 PMCID:PMC8874873

[65] Zhang J,Shu J.GJA1 Gene polymorphisms and topographic distribution of cranial MRI lesions in cerebral small vessel disease.Front Neurol2020;11:583974 PMCID:PMC7723976

[66] Erickson MA.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.J Cereb Blood Flow Metab2013;33:1500-13 PMCID:PMC3790938

[67] Abbott NJ,Hansson E.Astrocyte-endothelial interactions at the blood-brain barrier.Nat Rev Neurosci2006;7:41-53

[68] Nelson JW,Ajami N,Durgan D.Gut dysbiosis in the development of cerebral small vessel disease.FASEB J2018;32:582-4

[69] Shi Y.Update on cerebral small vessel disease: a dynamic whole-brain disease.Stroke Vasc Neurol2016;1:83-92 PMCID:PMC5435198

[70] Mustapha M,Aminuddin N,Ghazali MM.Cerebral small vessel disease (CSVD) - lessons from the animal models.Front Physiol2019;10:1317 PMCID:PMC6822570

[71] Kaiser D,Möller K.Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease.Acta Neuropathol Commun2014;2:169 PMCID:PMC4279586

[72] Bassi I,Hen G.Endolysosomal dysfunction in radial glia progenitor cells leads to defective cerebral angiogenesis and compromised blood-brain barrier integrity. BioRxiv 2023

[73] Hannawi Y.Cerebral small vessel disease: a review of the pathophysiological mechanisms.Transl Stroke Res2023;1-20

[74] Montagne A,Sweeney MD.Blood-brain barrier breakdown in the aging human hippocampus.Neuron2015;85:296-302 PMCID:PMC4350773

[75] Freeman LR.Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.Biochim Biophys Acta2012;1822:822-9 PMCID:PMC3412391

[76] Liao FF,Chen X.Endothelial nitric oxide synthase-deficient mice: a model of spontaneous cerebral small-vessel disease.Am J Pathol2021;191:1932-45 PMCID:PMC8647425

[77] Brown WR.Review: cerebral microvascular pathology in ageing and neurodegeneration.Neuropathol Appl Neurobiol2011;37:56-74 PMCID:PMC3020267

[78] Csiszar A,Edwards JG.Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function.Circ Res2002;90:1159-66

[79] Zlokovic BV.The blood-brain barrier in health and chronic neurodegenerative disorders.Neuron2008;57:178-201

[80] Baumbach GL.Cerebral circulation in chronic arterial hypertension.Hypertension1988;12:89-95

[81] Guy R,Wilczynski E.A novel rodent model of hypertensive cerebral small vessel disease with white matter hyperintensities and peripheral oxidative stress.Int J Mol Sci2022;23:5915 PMCID:PMC9180536

[82] Urso C.[Oxidative stress and endothelial dysfunction].Minerva Med2011;102:59-77

[83] Iadecola C.Hypertension and cerebrovascular dysfunction.Cell Metab2008;7:476-84 PMCID:PMC2475602

[84] Faraco G.Hypertension: a harbinger of stroke and dementia.Hypertension2013;62:810-7 PMCID:PMC3847558

[85] Rosenberg GA,Wardlaw JM.Consensus statement for diagnosis of subcortical small vessel disease.J Cereb Blood Flow Metab2016;36:6-25 PMCID:PMC4758552

[86] Hainsworth AH,Boltze J.Translational models for vascular cognitive impairment: a review including larger species.BMC Med2017;15:16 PMCID:PMC5264492

[87] Yan R,Lv F,Li Y.Rac1/Wave2/Arp3 pathway mediates rat blood-brain barrier dysfunction under simulated microgravity based on proteomics strategy.Int J Mol Sci2021;22:5165 PMCID:PMC8153163

[88] Tian F,Xu G.Surge of corticocardiac coupling in SHRSP rats exposed to forebrain cerebral ischemia.J Neurophysiol2019;121:842-52

[89] Ma Y,Li Y.Effects of Dl-3-n-butylphthalide on cognitive functions and blood-brain barrier in chronic cerebral hypoperfusion rats.Naunyn Schmiedebergs Arch Pharmacol2023;396:3207-20 PMCID:PMC10567816

[90] Yang L,Nan D,Guo H.Cognitive impairments and blood-brain barrier damage in a mouse model of chronic cerebral hypoperfusion.Neurochem Res2022;47:3817-28 PMCID:PMC9718874

[91] Zlokovic BV.Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.Nat Rev Neurosci2011;12:723-38 PMCID:PMC4036520

[92] Farkas E,Bari F.Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases.Brain Res Rev2007;54:162-80

[93] Kisler K,Montagne A.Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.Nat Rev Neurosci2017;18:419-34 PMCID:PMC5759779

[94] Jackman K.Neurovascular regulation in the ischemic brain.Antioxid Redox Signal2015;22:149-60 PMCID:PMC4281847

[95] Ergul A,Elgebaly MM,Fagan SC.Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature.Vascul Pharmacol2009;51:44-9 PMCID:PMC3732462

[96] Nelson AR,Sagare AP.Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.Biochim Biophys Acta2016;1862:887-900 PMCID:PMC4821735

[97] Byun K,Son M.Advanced glycation end-products produced systemically and by macrophages: a common contributor to inflammation and degenerative diseases.Pharmacol Ther2017;177:44-55

[98] Joutel A,Gosele C.Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease.J Clin Invest2010;120:433-45 PMCID:PMC2810078

[99] Ruchoux MM,Vandenhaute B,Vermersch P.Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.Acta Neuropathol1995;89:500-12

[100] Monet-Leprêtre M,Baron-Menguy C.Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.Brain2013;136:1830-45 PMCID:PMC3673461

[101] Karlström H,Dannaeus K,Lendahl U.A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling.Proc Natl Acad Sci USA2002;99:17119-24 PMCID:PMC139279

[102] Gupta A,Schweitzer AD.Neuroimaging of cerebrovascular disease in the aging brain.Aging Dis2012;3:414 PMCID:PMC3501396

[103] Klakotskaia D,Richardson RA,Schachtman TR.Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.PLoS One2018;13:e0195469 PMCID:PMC5895023

[104] Greenberg SM,Hernandez-Guillamon M,Sperling R.Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.Nat Rev Neurol2020;16:30-42 PMCID:PMC7268202

[105] Hampel H,De Strooper B.The β-secretase BACE1 in Alzheimer’s disease.Biol Psychiatry2021;89:745-56 PMCID:PMC7533042

[106] Yamamura H,Asai K,Yamamura H.Oxidative stress facilitates cell death by inhibiting Orai1-mediated Ca²⁺ entry in brain capillary endothelial cells.Biochem Biophys Res Commun2020;523:153-8

[107] Nation DA,Montagne A.Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.Nat Med2019;25:270-6 PMCID:PMC6367058

[108] DeStefano JG,Linville RM.Benchmarking in vitro tissue-engineered blood-brain barrier models.Fluids Barriers CNS2018;15:32 PMCID:PMC6280508

[109] Brown JA,Markov DA.Recreating blood-brain barrier physiology and structure on chip: a novel neurovascular microfluidic bioreactor.Biomicrofluidics2015;9:054124 PMCID:PMC4627929

[110] Bai T,Feng J.Advances in the role of endothelial cells in cerebral small vessel disease.Front Neurol2022;13:861714 PMCID:PMC9035937

[111] Kutikhin AG,Velikanova EA,Sinitskaya AV.Endothelial dysfunction in the context of blood-brain barrier modeling.J Evol Biochem Physiol2022;58:781-806 PMCID:PMC9243926

[112] Allt G.Pericytes: cell biology and pathology.Cells Tissues Organs2001;169:1-11

[113] Hawkins BT.The blood-brain barrier/neurovascular unit in health and disease.Pharmacol Rev2005;57:173-85

[114] Béguin EP,Hoogendijk AJ.Integrated proteomic analysis of tumor necrosis factor α and interleukin 1β-induced endothelial inflammation.J Proteomics2019;192:89-101

[115] Zhang L,Bao L.SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration.Signal Transduct Target Ther2021;6:337 PMCID:PMC8419672

[116] Fisher M,Howells DW.STAIR GroupUpdate of the stroke therapy academic industry roundtable preclinical recommendations.Stroke2009;40:2244-50 PMCID:PMC2888275

[117] Wang C,Yang M,Zhang S.Safflor yellow B suppresses angiotensin II-mediated human umbilical vein cell injury via regulation of Bcl-2/p22(phox) expression.Toxicol Appl Pharmacol2013;273:59-67

[118] Tharakan B,Hunter FA.Alpha lipoic acid attenuates microvascular endothelial cell hyperpermeability by inhibiting the intrinsic apoptotic signaling.Am J Surg2008;195:174-8

[119] Wu F,Tyml K.Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells.Free Radic Biol Med2007;42:124-31

[120] Leclech C,Muller L.Distinct contact guidance mechanisms in single endothelial cells and in monolayers.Adv Mater Inter2023;10:2202421

[121] Cai Z,Wan CQ,Zhou NK.Role of blood-brain barrier in Alzheimer's disease.J Alzheimers Dis2018;63:1223-34

[122] Gastfriend BD,Shusta EV.Modeling the blood-brain barrier: beyond the endothelial cells.Curr Opin Biomed Eng2018;5:6-12 PMCID:PMC6003712

[123] Park JS,Khan A.Establishing Co-culture blood-brain barrier models for different neurodegeneration conditions to understand its effect on BBB integrity.Int J Mol Sci2023;24:5283 PMCID:PMC10049378

[124] Sweeney MD,Zlokovic BV.Pericytes of the neurovascular unit: key functions and signaling pathways.Nat Neurosci2016;19:771-83 PMCID:PMC5745011

[125] Bhatia SN.Microfluidic organs-on-chips.Nat Biotechnol2014;32:760-72

[126] Peng B,Tong Z.Blood-brain barrier (BBB)-on-a-chip: a promising breakthrough in brain disease research.Lab Chip2022;22:3579-602

[127] Wang P,Zhang M.SARS-CoV-2 causes human BBB injury and neuroinflammation indirectly in a linked organ chip platform. BioRxiv 2010

[128] Kawakita S,Mou L.Organ-on-a-chip models of the blood-brain barrier: recent advances and future prospects.Small2022;18:e2201401

[129] Teixeira MI,Costa PC,Lamprou DA.Recent developments in microfluidic technologies for central nervous system targeted studies.Pharmaceutics2020;12:542 PMCID:PMC7356280

[130] Yoon JK,Shah Z,Mahajan A.Advanced human BBB-on-a-chip: a new platform for Alzheimer's disease studies.Adv Healthc Mater2021;10:e2002285 PMCID:PMC8349886

[131] Herland A,FitzGerald EA,Sleeboom JJF.Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip.PLoS One2016;11:e0150360 PMCID:PMC4773137

[132] Adriani G,Pavesi A,Goh ELK.A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier.Lab Chip2017;17:448-59

[133] Humpel C.Organotypic brain slice cultures: a review.Neuroscience2015;305:86-98 PMCID:PMC4699268

[134] Wevers NR,Gray T.A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport.Fluids Barriers CNS2018;15:23 PMCID:PMC6117964

[135] Wei W,Hierlemann A.3D in vitro blood-brain-barrier model for investigating barrier insults.Adv Sci2023;10:e2205752 PMCID:PMC10104638

[136] Chen X,Muok L,Li Y.Dynamic 3D on-chip BBB model design, development, and applications in neurological diseases.Cells2021;10:3183 PMCID:PMC8622822

[137] Potjewyd G,Hooper NM.3D hydrogel models of the neurovascular unit to investigate blood-brain barrier dysfunction.Neuronal Signal2021;5:NS20210027 PMCID:PMC8579151

[138] Bouhrira N,Sazer DW,Miller JS.Disturbed flow disrupts the blood-brain barrier in a 3D bifurcation model.Biofabrication2020;12:025020

[139] Gallo G,Savoia C.Endothelial dysfunction in hypertension: current concepts and clinical implications.Front Med2021;8:798958 PMCID:PMC8811286

[140] Paradis T,Basmaciyan L,Bon F.Tight junctions as a key for pathogens invasion in intestinal epithelial cells.Int J Mol Sci2021;22:2506 PMCID:PMC7958858

[141] Downie LE,Lim JKH.Longitudinal changes to tight junction expression and endothelial cell integrity in a mouse model of sterile corneal inflammation.Invest Ophthalmol Vis Sci2016;57:3477-84

[142] Velagapudi S,Poti F.Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways.Cardiovasc Res2024;120:476-89 PMCID:PMC11060483

[143] Voirin AC,Roche F.Inflammatory stress induced by a combination of cytokines (IL-6, IL-17, TNF-α) leads to a loss of integrity on bEnd.3 endothelial cells in vitro BBB model.Brain Res2020;1730:146647

[144] Nair AL,Overdevest R.Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions.Front Mol Neurosci2023;16:1250123 PMCID:PMC10561300

[145] Li Y,Huang TT.The peripheral immune response after stroke-A double edge sword for blood-brain barrier integrity.CNS Neurosci Ther2018;24:1115-28 PMCID:PMC6490160

[146] Morton L,Garza AP.Spatio-temporal dynamics of microglia phenotype in human and murine cSVD: impact of acute and chronic hypertensive states.Acta Neuropathol Commun2023;11:204 PMCID:PMC10729582

[147] Gao C,Tan Y.Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets.Signal Transduct Target Ther2023;8:359 PMCID:PMC10514343

[148] Song K,Zhang H.Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases.Oxid Med Cell Longev2020;2020:1-27

[149] Al-Kuraishy HM,Al-Niemi MS.The prospective effect of allopurinol on the oxidative stress index and endothelial dysfunction in Covid-19.Inflammation2022;45:1651-67 PMCID:PMC8865950

[150] Sun J,Su H,Zhang Y.The role of Nrf2 in the alteration of tight junction protein expression in choroid plexus epithelial cells created by lanthanum-activated MMP9.Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi2023;41:2-7

[151] Liu WC,Zhao ZH,Yin FQ.Effects of dietary supplementation of algae-derived polysaccharides on morphology, tight junctions, antioxidant capacity and immune response of duodenum in broilers under heat stress.Animals2021;11:2279 PMCID:PMC8388401

[152] Shaito A,Assaf R.Oxidative stress-induced endothelial dysfunction in cardiovascular diseases.Front Biosci2022;27:105

[153] Amruta N.ATN-161 ameliorates ischemia/reperfusion-induced oxidative stress, fibro-inflammation, mitochondrial damage, and apoptosis-mediated tight junction disruption in bEnd.3 cells.Inflammation2021;44:2377-94 PMCID:PMC8380192

[154] Chen S,Peng C.Targeting oxidative stress and inflammatory response for blood-brain barrier protection in intracerebral hemorrhage.Antioxid Redox Signal2022;37:115-34

[155] Grochowski C,Kamieniak P.Oxidative stress in cerebral small vessel disease. Role of reactive species.Free Radic Res2018;52:1-13

[156] Wang S,Zhang H.Aging exacerbates impairments of cerebral blood flow autoregulation and cognition in diabetic rats.Geroscience2020;42:1387-410 PMCID:PMC7525432

[157] Ali M,Njiru BN.VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer’s mice.Brain2022;145:1449-63 PMCID:PMC9150081

[158] Wu MM,Mazumder D.Improved accuracy of cerebral blood flow quantification in the presence of systemic physiology cross-talk using multi-layer Monte Carlo modeling.Neurophotonics2021;8:015001 PMCID:PMC7779997

[159] Ling YH,Pan LLH.Association between impaired dynamic cerebral autoregulation and BBB disruption in reversible cerebral vasoconstriction syndrome.J Headache Pain2023;24:170 PMCID:PMC10729479

[160] Ying Y,Yao T.Heterogeneous blood-brain barrier dysfunction in cerebral small vessel diseases.Alzheimers Dement2024;20:4527-39 PMCID:PMC11247670

[161] Jiménez-Sánchez L,Clancy U.Sex differences in cerebral small vessel disease: a systematic review and meta-analysis.Front Neurol2021;12:756887 PMCID:PMC8581736

[162] Chen BA,Meng LC.Sex-specific implications of inflammation in covert cerebral small vessel disease.BMC Neurol2024;24:220 PMCID:PMC11210151

[163] Collignon A,Ménard C.Sex, hormones and cerebrovascular function: from development to disorder.Fluids Barriers CNS2024;21:2 PMCID:PMC10768274

[164] Banks WA.Brain meets body: the blood-brain barrier as an endocrine interface.Endocrinology2012;153:4111-9 PMCID:PMC3423627

[165] Maggioli E,Mauro C.Estrogen protects the blood-brain barrier from inflammation-induced disruption and increased lymphocyte trafficking.Brain Behav Immun2016;51:212-22

[166] Weber CM.Sex differences in the blood-brain barrier and neurodegenerative diseases.APL Bioeng2021;5:011509 PMCID:PMC7968933

[167] van Zijl P, Knutsson L. In vivo magnetic resonance imaging and spectroscopy. Technological advances and opportunities for applications continue to abound.J Magn Reson2019;306:55-65 PMCID:PMC6703925

[168] Jahng GH,Ostergaard L.Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques.Korean J Radiol2014;15:554-77 PMCID:PMC4170157

[169] Acharya D,Cao J.Non-invasive spectroscopy for measuring cerebral tissue oxygenation and metabolism as a function of cerebral perfusion pressure.Metabolites2022;12:667 PMCID:PMC9323243

[170] Amendola C,Amelio G.Cerebral hemodynamics monitoring during extracorporeal membrane oxygenation in piglets; 2023. Available from: https://opg.optica.org/abstract.cfm?uri=ECBO-2023-126280F [Last accessed on 26 Jul 2023]

[171] Deseoe J,Pipping T.Cerebral blood flow velocity progressively decreases with increasing levels of verticalization in healthy adults. A cross-sectional study with an observational design.Front Neurol2023;14:1149673 PMCID:PMC10149656

[172] Nisha NN,Chowdhury MEH.A deep learning framework for the detection of abnormality in cerebral blood flow velocity using transcranial doppler ultrasound.Diagnostics2023;13:2000 PMCID:PMC10297317

[173] Jickling GC,Zhan X,Stamova B.microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets.PLoS One2014;9:e99283 PMCID:PMC4050059

[174] Alim I,Chen Y.Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke.Cell2019;177:1262-79.e25

[175] Zhang B,Lai BFL.Advances in organ-on-a-chip engineering.Nat Rev Mater2018;3:257-78

[176] Vanlandewijck M,Mäe MA.A molecular atlas of cell types and zonation in the brain vasculature.Nature2018;554:475-80

[177] Ståhl PL,Vickovic S.Visualization and analysis of gene expression in tissue sections by spatial transcriptomics.Science2016;353:78-82

[178] Banks WA.From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.Nat Rev Drug Discov2016;15:275-92